Article

Brief Communication

Ann Lab Med 2020; 40(5): 409-413

Published online September 1, 2020 https://doi.org/10.3343/alm.2020.40.5.409

Copyright © Korean Society for Laboratory Medicine.

Prevalence and Immunophenotypic Characteristics of Monoclonal B-Cell Lymphocytosis in Healthy Korean Individuals With Lymphocytosis

In Young Yoo, M.D.1 , Sung Hoan Bang, M.T.1 , Dae Jin Lim, M.T.1 , Seok Jin Kim, M.D.2 , Kyunga Kim, Ph.D.3,4 , Hee Jin Kim, M.D.1 , Sun-Hee Kim, M.D.1 , and Duck Cho, M.D.1

1Department of Laboratory Medicine and Genetics; 2Division of Hematology and Oncology, Department of Medicine; 3Statistics and Data Center, Research Institute for Future Medicine; 4Department of Digital Health, Samsung Advanced Institute for Health Sciences and Technology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

Correspondence to: Duck Cho, M.D.
Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 06351, Korea
Tel: +82-2-3410-2403
Fax: +82-2-3410-2719
E-mail: duck.cho@skku.edu

Received: September 23, 2019; Revised: November 13, 2019; Accepted: March 20, 2020

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Epidemiological studies of monoclonal B-cell lymphocytosis (MBL) have been conducted in limited geographical regions. Little is known about the prevalence of MBL in Asia. We investigated the prevalence and immunophenotypic characteristics of MBL in Koreans who had idiopathic lymphocytosis (lymphocyte count >4.0×109/L) and were ≥40 years of age. A total of 105 leftover peripheral blood samples met these criteria among those from 73,727 healthy individuals who visited the Health Promotion Center, Samsung Medical Center, Korea, from June 2018 to August 2019. The samples were analyzed using eight-color flow cytometry with the following monoclonal antibodies: CD45, CD5, CD10, CD19, CD20, CD23, and kappa and lambda light chains. The overall prevalence of MBL in the study population was 2.9% (3/105); there was one case of chronic lymphocytic leukemia (CLL)-like MBL (CD5+CD23+), one case of atypical CLL-like MBL (CD5+CD23), and one case of CD5MBL with a lambda restriction pattern. This is the first study on the MBL prevalence in an East Asian population, and it reveals a relatively low prevalence of MBL in healthy Korean individuals with lymphocytosis.

Keywords: Chronic lymphocytic leukemia, Monoclonal B-cell lymphocytosis, Prevalence, Immunophenotype, Korea

  1. Landgren O, Albitar M, Ma W, Abbasi F, Hayes RB, Ghia P, et al. B-cell clones as early markers for chronic lymphocytic leukemia. N Engl J Med 2009;360:659-67.
    Pubmed
  2. Shim YK, Middleton DC, Caporaso NE, Rachel JM, Landgren O, Abbasi F, et al. Prevalence of monoclonal B-cell lymphocytosis: a systematic review. Cytometry B Clin Cytom 2010;78:S10-8.
    Pubmed
  3. Criado I, Rodríguez-Caballero A, Gutiérrez ML, Pedreira CE, Alcoceba M, Nieto W, et al. Low-count monoclonal B-cell lymphocytosis persists after seven years of follow up and is associated with a poorer outcome. Haematologica 2018;103:1198-208.
    Pubmed
  4. Marti GE, Rawstron AC, Ghia P, Hillmen P, Houlston RS, Kay N, et al. Diagnostic criteria for monoclonal B-cell lymphocytosis. Br J Haematol 2005;130:325-32.
    Pubmed
  5. Nieto WG, Almeida J, Romero A, Teodosio C, López A, Henriques AF, et al. Increased frequency (12%) of circulating chronic lymphocytic leukemia-like B-cell clones in healthy subjects using a highly sensitive multicolor flow cytometry approach. Blood 2009;114:33-7.
    Pubmed
  6. Shim YK, Rachel JM, Ghia P, Boren J, Abbasi F, Dagklis A, et al. Monoclonal B-cell lymphocytosis in healthy blood donors: an unexpectedly common finding. Blood 2014;123:1319-26.
    Pubmed
  7. Rawstron AC, Ssemaganda A, de Tute R, Doughty C, Newton D, Vardi A, et al. Monoclonal B-cell lymphocytosis in a hospital-based UK population and a rural Ugandan population: a cross-sectional study. Lancet Haematol 2017;4:e334-40.
    Pubmed
  8. Aljurf M, Rawas F, Alnounou R, Bakshi N, Chaudhri N, Khalil S, et al. Prevalence and relative proportions of CLL and non-CLL monoclonal B-cell lymphocytosis phenotypes in the Middle Eastern population. Hematol Oncol Stem Cell Ther 2017;10:42-3.
    Pubmed
  9. Bajuk P, Furlan T, Podgornik H. Monoclonal B-cell lymphocytosis in the population of Slovenian region of Lower Carniola. Int J Lab Hematol 2016;38:341-6.
    Pubmed
  10. Parikh SA, Chaffee KG, Larson MC, Hampel PJ, Call TG, Ding W, et al. Outcomes of a large cohort of individuals with clinically ascertained high-count monoclonal B-cell lymphocytosis. Haematologica 2018;103:e237-40.
    Pubmed
  11. Rossi D, Bruscaggin A, Spina V, Rasi S, Khiabanian H, Messina M, et al. Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness. Blood 2011;118:6904-8.
    Pubmed
  12. Schnaiter A, Paschka P, Rossi M, Zenz T, Bühler A, Winkler D, et al. NOTCH1, SF3B1, and TP53 mutations in fludarabine-refractory CLL patients treated with alemtuzumab: results from the CLL2H trial of the GCLLSG. Blood 2013;122:1266-70.
    Pubmed
  13. Morabito F, Mosca L, Cutrona G, Agnelli L, Tuana G, Ferracin M, et al. Clinical monoclonal B lymphocytosis versus Rai 0 chronic lymphocytic leukemia: a comparison of cellular, cytogenetic, molecular, and clinical features. Clin Cancer Res 2013;19:5890-900.
    Pubmed
  14. Lanasa MC, Allgood SD, Slager SL, Dave SS, Love C, Marti GE, et al. Immunophenotypic and gene expression analysis of monoclonal B-cell lymphocytosis shows biologic characteristics associated with good prognosis CLL. Leukemia 2011;25:1459-66.
    Pubmed
  15. Jang MA, Yoo EH, Kim K, Kim WS, Jung CW, Kim SH, et al. Chronic lymphocytic leukemia in Korean patients: frequent atypical immunophenotype and relatively aggressive clinical behavior. Int J Hematol 2013;97:403-8.
    Pubmed
  16. Tomomatsu J, Isobe Y, Oshimi K, Tabe Y, Ishii K, Noguchi M, et al. Chronic lymphocytic leukemia in a Japanese population: varied immunophenotypic profile, distinctive usage of frequently mutated IGH gene, and indolent clinical behavior. Leuk Lymphoma 2010;51:2230-9.
    Pubmed
  17. Amato D, Oscier DG, Davis Z, Mould S, Zheng J, Kolomietz E, et al. Cytogenetic aberrations and immunoglobulin VH gene mutations in clinically benign CD5- monoclonal B-cell lymphocytosis. Am J Clin Pathol 2007;128:333-8.
    Pubmed
  18. Wang C, Amato D, Fernandes B. CD5-negative phenotype of monoclonal B-lymphocytosis of undetermined significance (MLUS). Am J Hematol 2002;69:147-9.
    Pubmed
  19. Parker E, Macdonald JR, Wang C. Molecular characterization of a t(2;7) translocation linking CDK6 to the IGK locus in CD5(−) monoclonal B-cell lymphocytosis. Cancer Genet 2011;204:260-4.
    Pubmed